Involvement of c-Jun-JNK pathways in the regulation of programmed cell death of developing chick embryo spinal cord motoneurons.
Key features of developmentally regulated programmed cell death (PCD) have been described for the first time in the chick nervous system. JNK/c-Jun pathway was involved in early events determining normal and pathological neuronal death as shown in experimental models. In the chick embryo, PCD of motoneurons (MNs) in ovo occurs within a well-defined temporal window and can be subjected to experimental manipulation. Taking advantage of this in vivo system, we explored the role of c-Jun and JNK pathway in the regulation of PCD in MNs. By using specific antibodies against phospho-c-Jun (Ser 63, 73) and JNK we demonstrated that before MNs acquire apoptotic phenotype there is an increase in c-Jun. Blockage of neuromuscular activity by the GABA agonist muscimol reduces PCD and diminishes c-Jun immunoreactivity in MNs. Extensive induction of PCD, either due to injection of beta-bungarotoxin or limb bud removal, is also preceded by an increase in c-Jun immunoreactivity that is also associated with upregulation of phospho-c-Jun and JNK. Translocation of JNK from cytoplasm to MN nuclei was also detected. After acute application of beta-bungarotoxin, which is a strong apoptotic stimulus for MNs, c-Jun phosphorylation occurs on serine 73, whereas serine 63 is the main site for c-Jun phosphorylation after limb bud removal. These results demonstrated that the JNK/c-Jun pathway is involved in the decision phase of normal and induced apoptosis in MNs. Pharmacological interventions involving this pathway should be explored as a potential therapeutic target for promoting MN survival.
Ribera
Joan
J
Universitat de Lleida, Facultat de Medicina, Departament de Ciències Mèdiques Bàsiques, Lleida, Spain. joan.ribera@cmb.udl.es
Ayala
Victoria
V
Casas
Celia
C
D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D001692:Biological Transport; D002038:Bungarotoxins / Q000494:pharmacology; D002467:Cell Nucleus / Q000378:metabolism; D002642:Chick Embryo / Q000166:cytology / Q000502:physiology*; D005121:Extremities / Q000196:embryology; D018755:GABA Agonists / Q000494:pharmacology; D048031:JNK Mitogen-Activated Protein Kinases / Q000378:metabolism / Q000502:physiology*; D009046:Motor Neurons / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D009118:Muscimol / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000187:drug effects; D010766:Phosphorylation; D016755:Proto-Oncogene Proteins c-jun / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology*; D013116:Spinal Cord / Q000196:embryology*
D002038:Bungarotoxins; D018755:GABA Agonists; D016755:Proto-Oncogene Proteins c-jun; D009118:Muscimol; D048031:JNK Mitogen-Activated Protein Kinases